Abstract 4896: Real-time imaging of pancreatic cancer stem cells for identification of the selectively targeting therapy.

Abstract

Abstract Identification and purification of cancer stem cells (CSCs) should offer a clue of the therapeutic targets, but their heterogeneous expansion remains the significant obstacle of studies. One of the solutions might be establishment of real-time monitoring of CSC, based on fluorescence imaging with the intrinsically low proteasome activity. The monitoring system in human pancreatic cancer cells proved directly the asymmetric division of CSC to generate non-CSC. Real-time chemoresistance of the CSCs and remarkable tumorigenicity (as few as 10 cells) indicated their preclinical significance. The synthetic lethal screening was applied to identify a novel compound targeting specifically the pancreatic CSCs. It inhibited nuclear accumulation of beta-catenin in the pancreatic CSCs. Anti-CSC effects of the compound were confirmed by in vitro dynamic images and in vivo tumor analyses. The real-time monitoring system of CSCs is an innovative strategy providing a visible target that should lead to the discovery of successful therapies directed toward CSCs of aggressive cancers. Citation Format: Shinji Tanaka, Rama Adikrisna, Satoshi Matsumura, Daisuke Ban, Takanori Ochiai, Takumi Irie, Atsushi Kudo, Noriaki Nakamura, Shoji Yamaoka, Shigeki Arii. Real-time imaging of pancreatic cancer stem cells for identification of the selectively targeting therapy. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 4896. doi:10.1158/1538-7445.AM2013-4896 Note: This abstract was not presented at the AACR Annual Meeting 2013 because the presenter was unable to attend.